Found 9 matching trials
Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC) PHASE4 The purpose of this study was to understand whether participants could moun...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults PHASE2 The purpose of this trial is to assess the safety and relative efficacy of ...
Show More Location
Pinnacle Research Group, LLC
Learn More & Join Trial
Immunocompromised Swiss Cohorts Based Trial Platform PHASE3 This study is to set up a flexible trial platform using two existing nation...
Show More Location
University Hospital Basel
Learn More & Join Trial
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection PHASE2 The primary objective of the study is to determine the relative efficacy of...
Show More Status
Active Not Recruiting
Location
Pinnacle Research Group
Learn More & Join Trial
Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG PHASE1 SpiN-Tec MCTI UFMG will be used as a vaccine booster against COVID-19 and w...
Show More Location
Faculdade de Medicina da UFMG - Unidade de Pesquisa Clínica em Vacinas (UPqVac)
Learn More & Join Trial
Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine PHASE2 A multicenter, randomized, double-blind, active comparator, non-inferiority...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults PHASE2 This clinical trial is designed to assess the safety, tolerability and immu...
Show More Location
Paratus research Canberra Clinic
Learn More & Join Trial
A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults. PHASE1 The purpose of this research study is to evaluate the safety of and the bod...
Show More Location
Momentum Clinical Research Darlinghurst
Learn More & Join Trial
A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines PHASE3 The study is a randomized, double-blind, and positive-controlled Phase III ...
Show More Location
Al Kuwait Hospital (Al Baraha Hospital)
Learn More & Join Trial